Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.00    0.00 (0.00%)
Bid:
27.00
Ask:
29.00
Spread: 2.00 (7.407%)
Market Cap: £73.24m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Statement re NAV, Dividend and Offer

27 Jan 2014 17:00

RNS Number : 6223Y
Maven Income and Growth VCT 5 PLC
27 January 2014
 



Maven Income and Growth VCT 5 PLC

 

Net Asset Value, Proposed Final Dividend and Offer for Subscription

 

The Directors of Maven Income and Growth VCT 5 PLC confirm that the unaudited net asset value of the Company as at 30 November 2013 was 37.09p per Ordinary Share.

 

The Directors are recommending the payment of a final dividend of 1.35p per Ordinary Share in respect of the year ended 30 November 2013, to be paid on 30 May 2014 to Shareholders on the register at close of business on 9 May 2014. Subject to the approval of Shareholders at the Annual General Meeting, the proposed final dividend will result in an aggregate payment of 2.00p per share in respect of the year ended 30 November 2013, which represents an increase of 21.21% over the total payment for the prior year.

 

Furthermore, the Directors confirm an unaudited net asset value of the Company as at 21 January 2014 of 40.63p per Ordinary Share, representing an increase of 9.54% over the net asset value as at 30 November 2013 and an increase of 11.71% over the previously announced net asset value of 36.37p at 10 October 2013, which was used as the basis for the Offer Price set out in the Prospectus for the Offer for Subscription issued by the Company on 24 October 2013. The rise in the net asset value over that period reflects the performance of AIM quoted securities in general and, in particular, certain investments in the Company's portfolio within the energy sector. As the Board recognises that the share prices of its AIM quoted investments in general, and these investments in particular, may remain volatile, the Directors intend to review the net asset value of the Company prior to the first allotment of shares under the Offer for Subscription, due to take place on or after 3 February 2014, and reserve their discretion to amend the Offer Price in accordance with the Prospectus. Any variation in the Offer Price will be announced through a regulatory information service.

 

In accordance with Listing Rule 15.5.1, and further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Section 118C of the Financial Services and Markets Act 2000) that the Directors and the Company may have in their possession relating to the Company during the period leading up to the announcement of its financial results for the year ended 30 November 2013 has previously been notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

27 January 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRSEAFMWFLSEIF
Date   Source Headline
6th Oct 202111:23 amRNSNet Asset Value(s)
20th Sep 20214:57 pmRNSStatement re Change of Registrar
10th Sep 20219:59 amRNSDirector/PDMR Shareholding
10th Sep 20219:57 amRNSDirector/PDMR Shareholding
10th Sep 20219:31 amRNSIssue of Equity
7th Sep 20213:09 pmRNSStatement re Dividend Investment Scheme
10th Aug 20214:31 pmRNSHalf-year Report
5th Aug 20219:17 amRNSStatement re NAV and Interim Dividend
7th May 20213:54 pmRNSTransaction in Own Shares
7th May 20212:06 pmRNSDirector/PDMR Shareholding
7th May 20212:06 pmRNSDirector/PDMR Shareholding
7th May 20212:03 pmRNSIssue of Equity
5th May 202112:56 pmRNSTransaction in Own Shares
4th May 20214:01 pmRNSStatement re Dividend Investment Scheme
4th May 20213:54 pmRNSDirector/PDMR Shareholding
4th May 20213:25 pmRNSIssue of Equity
27th Apr 20211:46 pmRNSNet Asset Value(s)
27th Apr 20211:17 pmRNSResult of AGM
6th Apr 20217:00 amRNSIssue of Equity
1st Apr 202110:33 amRNSStatement re Offer for Subscription
23rd Mar 20213:41 pmRNSPublication of Suppl.Prospcts
15th Mar 20213:37 pmRNSAnnual Financial Report
3rd Mar 20213:05 pmRNSHolding(s) in Company
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSIssue of Equity
24th Feb 20214:41 pmRNSTransaction in Own Shares
16th Feb 20217:00 amRNSNet Asset Value and Proposed Final Dividend
8th Feb 20213:59 pmRNSStatement re Offer for Subscription
28th Jan 20214:40 pmRNSStatement re Offer for Subscription
30th Nov 20204:47 pmRNSTransaction in Own Shares
27th Nov 202010:45 amRNSResult of General Meeting
23rd Nov 20205:03 pmRNSTransaction in Own Shares
16th Nov 20204:49 pmRNSTransaction in Own Shares
26th Oct 20207:00 amRNSPublication of a Prospectus
16th Oct 202010:15 amRNSNet Asset Value(s)
28th Aug 202011:27 amRNSDirector/PDMR Shareholding
28th Aug 202010:31 amRNSIssue of Equity
26th Aug 20205:24 pmRNSTransaction in Own Shares
21st Aug 20204:11 pmRNSStatement re NAV and DIS
31st Jul 20207:00 amRNSHolding(s) in Company
29th Jul 20205:11 pmRNSTransaction in Own Shares
29th Jul 202010:55 amRNSHalf-year Report
22nd Jul 20202:25 pmRNSStatement re Intended Joint Offersfor Subscription
16th Jul 20202:38 pmRNSStatement re NAV and Interim Dividend
29th Jun 20202:44 pmRNSDirector Declaration
14th May 20204:47 pmRNSTransaction in Own Shares
29th Apr 20204:36 pmRNSTransaction in Own Shares
28th Apr 202012:12 pmRNSResult of AGM
26th Mar 20205:25 pmRNSUpdate on Net Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.